Trademark: 88729359
Word
DISCOVERY LABS
Status Date
Monday, November 6, 2023
Filing Date
Monday, December 16, 2019
Published for Opposition
Tuesday, February 9, 2021
Abandoned Date
Monday, November 6, 2023
40 Manufacturing services for others in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; Manufacturing process consulting
45 Regulatory compliance consulting in the fields of pharmaceuticals, medicines, biopharmaceuticals, and gene therapy
42 Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Research and development of new products for others; Process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; Scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; Quality control for others; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Material testing; Product quality testing; Scientific laboratory services; Scientific research
Dec 19, 2019
New Application Entered
Dec 19, 2019
New Application Office Supplied Data Entered
Mar 12, 2020
Assigned To Examiner
Mar 19, 2020
Non-Final Action Written
Mar 19, 2020
Non-Final Action E-Mailed
Mar 19, 2020
Notification Of Non-Final Action E-Mailed
Sep 15, 2020
Teas Response To Office Action Received
Sep 15, 2020
Correspondence Received In Law Office
Sep 15, 2020
Teas/Email Correspondence Entered
Sep 21, 2020
Assigned To Examiner
Sep 29, 2020
Final Refusal Written
Sep 29, 2020
Final Refusal E-Mailed
Sep 29, 2020
Notification Of Final Refusal Emailed
Dec 22, 2020
Teas Request For Reconsideration Received
Dec 22, 2020
Correspondence Received In Law Office
Dec 22, 2020
Teas/Email Correspondence Entered
Jan 4, 2021
Approved For Pub - Principal Register
Jan 20, 2021
Notification Of Notice Of Publication E-Mailed
Feb 9, 2021
Published For Opposition
Feb 9, 2021
Official Gazette Publication Confirmation E-Mailed
Apr 6, 2021
Noa E-Mailed - Sou Required From Applicant
Sep 14, 2021
Sou Teas Extension Received
Sep 14, 2021
Sou Extension 1 Filed
Sep 14, 2021
Sou Extension 1 Granted
Sep 16, 2021
Notice Of Approval Of Extension Request E-Mailed
Mar 23, 2022
Sou Teas Extension Received
Mar 23, 2022
Sou Extension 2 Filed
Mar 23, 2022
Sou Extension 2 Granted
Mar 25, 2022
Notice Of Approval Of Extension Request E-Mailed
Sep 16, 2022
Sou Teas Extension Received
Sep 16, 2022
Sou Extension 3 Filed
Sep 16, 2022
Sou Extension 3 Granted
Sep 20, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 3, 2023
Sou Teas Extension Received
Apr 3, 2023
Sou Extension 4 Filed
Apr 3, 2023
Sou Extension 4 Granted
Apr 5, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 6, 2023
Abandonment - No Use Statement Filed
Nov 6, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Trademark Alertz updated from USPTO on 2030-01-24
